General Range

FORLOXACIN-D

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

FORLOXACIN-D Eye Drops by Fortune Labs contain Moxifloxacin and Dexamethasone, a combination formulated for managing selected bacterial eye infections accompanied by inflammation. Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA replication, helping control susceptible bacteria. Dexamethasone is a corticosteroid that reduces inflammation, redness, and swelling. FORLOXACIN-D may be prescribed for specific inflammatory eye conditions requiring antibacterial treatment under ophthalmologist supervision. Available in a convenient 5 ml dropper bottle, this product is part of Fortune Labs' ophthalmic pharmaceutical portfolio. Fortune Labs offers Ophthalmic PCD Pharma Franchise and distribution opportunities across India. Contact Fortune Labs for wholesale pricing, product availability, and franchise enquiries. Use strictly as prescribed, as steroid-containing eye drops require careful monitoring.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Moxifloxacin + Dexamethasone Eye Drops
Packaging Type: Sterile Plastic Dropper Bottle with Outer Carton
Packaging Size: 5 ml
Dosage Form: Ophthalmic Eye Drops
Treatment: Bacterial eye infections accompanied by inflammation, redness, swelling, and irritation, including selected post-operative eye conditions under ophtha
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?